"Collaboration between Indonesia and CEPI is very important in supporting the progress of the vaccine industry and local manufacturing capacity, as well as the development of a pandemic response ecosystem in the country,” Deputy Foreign Minister Arrmanatha Nasir stated during a meeting with representatives of CEPI here on Thursday (February 13).
Arrmanatha expressed his appreciation for CEPI's support for Indonesia and hoped the organization would foster partnerships with Indonesian vaccine producers.
He stated that advancing this partnership would ensure that Indonesia achieves its goal of becoming a center for vaccine research, production, and distribution in the region.
"Moreover, this is in line with President Prabowo's priorities," Arrmanatha added.
He also expressed hope that CEPI could support the development of a tuberculosis vaccine in Indonesia, as eradicating the disease is a priority of the Indonesian government and aligns with the organization's program.
Meanwhile, CEPI Board Chair Professor Jane Halton and CEPI CEO Dr. Richard Hatchett expressed their appreciation for the Indonesian Ministry of Foreign Affairs' role in initiating the collaboration.
The role of the Indonesian Ministry of Foreign Affairs is very crucial in encouraging Indonesia to join CEPI. Indonesia has been one of CEPI's strategic partners since 2020, Professor Halton remarked.
CEPI also highlighted the importance of supporting the increase of Indonesia's vaccine production capacity by strengthening cooperation with state-owned pharmaceutical company PT Bio Farma.
CEPI was established in Davos, Switzerland, in 2017 by Norway, India, the World Economic Forum (WEF), the Bill & Melinda Gates Foundation, and the Wellcome Group.
The coalition focuses on developing health products to prepare for future health risks.
Related news: G20: 2nd HMM to discuss five health sector-related focus areas
Translator: Nabil Ihsan, Yashinta Difa
Editor: Rahmad Nasution
Copyright © ANTARA 2025
